EVIDENCE DEVELOPMENT
Leading the Development of Scientifically Credible Evidence to Inform Product Value
eMAX Health real-world evidence development research is highly focused on rigorous U.S. retrospective data studies, European bespoke chart reviews, Global PRO studies leveraging mobile assessment tools, and graphically creative economic modeling.
eMAX Health transforms your scientific and economic evidence into value stories and communications tactics, supported by our agency-quality digital and print creative capabilities. Our extensive creative services translate value stories into visually stunning interactive budget impact models, slide decks, and digital customer engagement tools.
Proprietary Research Database
Our proprietary EMRClaims+ U.S. database integrates more than 2 million lives of national managed care claims with more than 20 million electronic medical records offering chart-level details and all-inclusive longitudinal follow-up.
Publication Spotlight
ASTHMA
Published in Allergy Asthma Proc.
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma
ASTHMA MARKERS
Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthma
BIOLOGICS IN THERAPY
Published in J Allergy Clin Immunol Pract.
Assessment of Real-World Escalation to Biologics in US Patients With Asthma
MIGRAINE
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
RISK EQUATIONS & MODELS
Published in J Manag Care Spec Pharm.
Progression to Uncontrolled Severe Asthma: A Novel Risk Equation
VASCULAR
Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective
Advanced Analytics and Research for Value Evidence Development
Budget Impact modeling
Cost-effectiveness modeling
Value-based (performance) contract modeling
Systematic and structured literature reviews
Meta-analyses